GlassScriptPhysician profile
Kartik Mani
NPI 1689869885
$1,253.73
in general payments reported to CMS, 2019-2025
12 companies · $629 in 2025
The $629 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.66 · 2020: $137 · 2021: $124 · 2022: $147 · 2023: $131 · 2025: $629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $759.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $344.28 | 2020-2025 | |
| Medtronic, INC. | $271.24 | 2021-2022 | |
| Terumo Medical Corporation | $227.76 | 2025 | |
| Abbott Laboratories | $130.81 | 2023 | Quadra Assura |
| Cardiovascular Systems INC. | $77.27 | 2019 | |
| Philips North America LLC | $72.10 | 2025 | Coronary Other |
| Pfizer INC. | $54.58 | 2025 | |
| Penumbra, INC. | $25.00 | 2025 | Penumbra System |
| Teleflex LLC | $16.21 | 2025 | Guideliner |
| Boston Scientific Corporation | $14.93 | 2025 | Avvigo Guidance System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.16 | 2025 | Lifevest |
| Z-Medica, LLC | $8.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kartik Mani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.